Spiramycin

螺旋霉素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameSpiramycin
Drug Alias Name史霉素spiramycinumespiramicina螺旋链霉素spiramycine +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionProtein biosynthesis inhibitors50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsHIV InfectionsToxoplasmosisProtozoan Infections +[5] 
Global Approved IndicationsToxoplasmosisProtozoan InfectionsBacterial Infections
Approved Indications in ChinaProtozoan InfectionsBacterial Infections
Original Approved Country/TerritoryFrance
Original Approved Date1955/02/08
Country/TerritoryCanadaUnited StatesFrance +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiSinopharm Wuhan Zhonglian Siyao Pharmaceutical Co Ltd
Inactive CompaniesRhone Poulenc Rorer Sa
Active IndicationsToxoplasmosisProtozoan InfectionsBacterial Infections
Inactive IndicationsHIV InfectionsCryptosporidiosis

Other Information

ATC CodeJ01FA02
Related LinksWikipediaDrugBankKEGG